Low Standard Rate Ends Fri, May 24, for Popular Bay Area Pharma Market Research Conference (June 12-13, San Francisco). Secure Your Seat & Register: https://lnkd.in/dnKgXhvN Benefit from the Impressive Agenda: https://lnkd.in/drjbgTfm We look forward to an extraordinary event and hope to see you soon! Bay Area Pharma Market Research Conference & Exhibition June 12-13, 2024 (Wednesday - Thursday) Embassy Suites by Hilton San Francisco Airport 250 Gateway Boulevard South San Francisco, California 94080 hotel phone: +1 (650) 589-3400 conference info phone: +1 (212) 228-7974 https://lnkd.in/e-wmA6X info@pharmamarketresearchconference.com #pharma #biotech #medicaldevices #marketresearch #PMRC2024 #BayArea #WestCoast #SanFrancisco
Pharma Market Research Conference PMRC’s Post
More Relevant Posts
-
Heading to Clinical Trial Supply East next week, One Worldwide Logistics will be there! Let’s connect and discuss your logistics needs! Who else is attending? #CTSEastcoast #Clinicaltrials #Healthcare #Pharma #biotechnology #Lifescience #Logistics
📢With just less than a week left- This is your final reminder to confirm your place for the 22nd Annual Clinical Trial Supply East Coast conference! This is your exclusive opportunity to immerse yourself in a dynamic atmosphere of learning, collaboration, and innovation. 📅 Event Date: 5 - 6 November 2024 📍 Location: Sheraton Valley Forge, King of Prussia, PA, USA 🌐 Confirm Your Spot Now: Use code HAMK>>>https://shorturl.at/Itxm4 #CTSEastCoast #ClinicalTrials #Healthcare #Pharma #biotechnology
-
Very interesting article showing how important is to differentiate from the existing trends. PreTT is already working with Astatine 211 and we believe as well it's gonna be the next generation of radiotheranostics. #Astatine #radiopharmaceuticals
As the R&D and the clinical interest for Actinium-225 labeled molecules increases, questions regarding future availability of industrial-scale quantities of this isotope cast doubt on the marketing viability of 225Ac-labeled drugs. 🔍 Explore further into this topic with our president & founder Richard Zimmermann's article: https://buff.ly/44nEqLE Would you like to see this and more exclusive articles? Access the latest edition of Radiotheranostics Today - https://buff.ly/3PYq9iB
-
While we embrace the decade and clinical benefits of 225Ac, it is now time to prepare for the next generation of (shorter half-life) radiopharmaceuticals
As the R&D and the clinical interest for Actinium-225 labeled molecules increases, questions regarding future availability of industrial-scale quantities of this isotope cast doubt on the marketing viability of 225Ac-labeled drugs. 🔍 Explore further into this topic with our president & founder Richard Zimmermann's article: https://buff.ly/44nEqLE Would you like to see this and more exclusive articles? Access the latest edition of Radiotheranostics Today - https://buff.ly/3PYq9iB
-
We are excited to share the third session of our Fireside series, brought to you in partnership with FLUIDDA. In this session, our panel of experts—Dr. Eleanor Canipa and Dr. Will Ganley from Nanopharm, alongside Dr. Jan De Backer from Fluidda—explore two critical topics: 1️⃣ The FDA's endorsement of optional in-silico studies and their growing importance in bioequivalence assessments. 2️⃣ The challenges and opportunities in validating in-silico platforms for the development of generics. Do you have any questions? Our team will be attending Drug Delivery to the Lungs Conference (DDL) 2024 in Edinburgh this December. Feel free to reach out to our team there and ask any question you have. #NanopharmInnovates #FDAUpdates #PharmaceuticalInnovation #SmartTrack #OINDP #MedicalDevice
-
Check out this video from the Nanopharm & Fluidda teams
We are excited to share the third session of our Fireside series, brought to you in partnership with FLUIDDA. In this session, our panel of experts—Dr. Eleanor Canipa and Dr. Will Ganley from Nanopharm, alongside Dr. Jan De Backer from Fluidda—explore two critical topics: 1️⃣ The FDA's endorsement of optional in-silico studies and their growing importance in bioequivalence assessments. 2️⃣ The challenges and opportunities in validating in-silico platforms for the development of generics. Do you have any questions? Our team will be attending Drug Delivery to the Lungs Conference (DDL) 2024 in Edinburgh this December. Feel free to reach out to our team there and ask any question you have. #NanopharmInnovates #FDAUpdates #PharmaceuticalInnovation #SmartTrack #OINDP #MedicalDevice
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Biosecure Act influence still felt even as China bill stalls >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #pharmaceutical #productmarketing
-
Do you seek to expand the "Indications for Use" of your bone graft substitute product to include Interbody Fusion through a 510(k) pathway?? Let BCVG lead your effort as we have successfully done for others in less than 30 days of review time at FDA. #bonegraft #spinesurgery
#DidYouKnow BCVG can secure FDA clearance for bone grafts in interbody fusion in less than 30 Days. Using a unique logic and strategy to secure market authorization for Bone Grafts previously cleared for posterolateral fusion only, Dr. Laura Rose -- formerly of FDA -- has partnered with numerous client partners to get their products cleared in less than 30 days, with no new data required. Reach out if you'd like to learn more about how BCVG can help expand your claim set for bone grafts and more. Schedule a meeting with us today: https://lnkd.in/em7xgH8i #BruderConsulting #BCVG #StrategicPlanning #PortfolioOptimization #FDA #medtech #biotech #managementconsulting #IntegratedInsights
-
-
Step into a world of extraordinary growth and #opportunity at the 35th Annual European Pharma Congress, taking place on March 10-11, 2025, in Rome, Italy. This premier event serves as a dynamic platform for #professional development and industry #innovation. Here’s why you won’t want to miss this unique opportunity. · Expand Your Knowledge Base · Enhance Your Skillset · Enhance Your Professional Profile · Join a Global Community For more Details please visit : https://cutt.ly/IeDzDqIl #PharmaEurope2025 #PharmaCongress #EuropeanPharma #Callforabstracts #Rome2025 #PharmaceuticalInnovation #BiotechSummit #PharmaGrowth #FutureOfPharma #PharmaConference #DrugDiscovery #HealthcareInnovation #RegenerativeMedicine #PharmaLeaders #GlobalPharma #PharmaOpportunities #PharmaIndustry #RomeConference #LifeSciences #SubmitProposals
-
-
Due to record demand, we are now sold out of in-person passes to attend Bio€quity Europe in San Sebastián. You may still attend this VIP event via a Digital Pass, which allows you to: ➤ Schedule virtual partnering meetings with Bio€quity delegates May 21-22 ➤ Watch all session recordings for 30 days after the event. ➤ Receive the exclusive conference report from Insights Partner McKinsey & Company plus the Bio€quity “Scene Setter” report from BioCentury Inc. Register for a digital pass: https://loom.ly/HNklMqQ If you wish to attend #BioEquityEurope in-person, please join the Wait List: https://loom.ly/mo-dKj0 Those on the Wait List who have registered for a Digital Pass will receive priority review. Please ensure you have an in-person ticket before you book travel. #biotech #biopharma #venturecapital #drugdevelopment #businessdevelopment #pharma #investor #investors #lifesciences #VCs
-
-
Join us at the Marriott Downtown CF Toronto Eaton Centre tomorrow for the Clinical Regulatory Guidance Round Table, hosted by Caidya. This pivotal event features industry veterans Bani Tchekanova and Blaine Van Leuven, who bring a wealth of knowledge in regulatory and strategic development. Dive deep into discussions on clinical regulatory strategies and accelerated approval programs. Don’t miss out on this opportunity to enhance your understanding and network with peers! https://ow.ly/gJAQ50T9fMh #Biotech #Pharma #RegulatoryInsights
-
